| 標題: | Clinical Outcomes and Adverse Effects in Septic Patients with Impaired Renal Function Who Received Different Dosages of Cefoperazone-Sulbactam |
| 作者: | Tai, Chien-Hsiang
Tang, Hung-Jen
Lee, Chen-Hsiang |
| 貢獻者: | Chang Gung Memorial Hospital
Chi Mei Hospital
Chi Mei Hospital
Department of Health and Nutrition, Chia Nan University of Pharmacy & Science
Chang Gung University |
| 關鍵字: | resistant
therapy
pharmacokinetics
pneumonia
efficacy |
| 日期: | 2022 |
| 上傳時間: | 2023-12-11 13:56:31 (UTC+8) |
| 出版者: | MDPI |
| 摘要: | This study aimed to compare clinical outcomes and adverse effects in septic patients with impaired renal function who received different dosages of cefoperazone-sulbactam (CFP-SUL 1 g/1 g or 2 g/2 g every 12 h). The retrospective study was conducted using the Chang Gung Research Database to include adult patients who had renal insufficiency presented with septicemia caused by Gram-negative organisms and had received CFP-SUL for more than 1 week. A total of 265 patients (44 in the CFP-SUL 1 g/1 g group and 221 in the CFP-SUL 2 g/2 g group) were eligible to be included in this study. After 1:3 propensity score matching, 41 and 123 patients in the CFP-SUL 1 g/1 g and CFP-SUL 2 g/2 g groups, respectively, were included for analyses. There were no significant between-group differences in all-cause mortality rates and adverse effects, including prolonged prothrombin time. A logistic regression model showed that the Pitt bacteremia score was related to all-cause mortality rate and prolonged prothrombin time was associated with renal replacement therapy. The adverse effects of CFP-SUL did not increase in septic patients with impaired renal function receiving CFP-SUL 2 g/2 g Q12H. However, this study may be underpowered to reveal a difference in all-cause mortality. |
| 關聯: | Antibiotics-Basel, v.11, n.4, pp.460 |
| 顯示於類別: | [保健營養系(所) ] 期刊論文
|
